BDC2.5 Mimotope 1040-63 – 1 mg

Overview

The BDC2.5 Mimotope 1040-63 (1 mg) is a specialized peptide designed for researchers studying type 1 diabetes (T1D). This autoimmune disease results from the destruction of insulin-producing pancreatic islet beta cells by autoreactive T cells. The BDC2.5 mimotope serves as a vital tool in advancing our understanding of the immune response involved in T1D and the role of antigen presentation in this disease.

Key Features

• Designed specifically for type 1 diabetes research.
• Supports studies on the antigen presentation of peptides to islet autoantigen-specific T cells.
• Provides insights into the mechanisms of T1D and potential therapeutic avenues.
• High purity and quality for reliable results.
• Designed to facilitate your research needs.

Specifications

FAQ

What is the BDC2.5 Mimotope used for?

The BDC2.5 mimotope is utilized primarily in research related to type 1 diabetes, aiding in the study of how T cells target pancreatic islet cells.

How is this peptide sourced?

Our peptides, including the BDC2.5 Mimotope, are synthesized in a controlled environment to ensure high quality and purity.

Can this peptide be used in clinical studies?

While the BDC2.5 Mimotope is intended for research purposes, its implications in the understanding of T1D may pave the way for future clinical applications.

Enhance your research on type 1 diabetes with the BDC2.5 Mimotope 1040-63, now available for sale. This peptide is essential for gaining insights into the mechanisms that underlie autoimmune responses. Explore our full range of peptides to find more tools tailored for your studies.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled